Logo image of RFMZ

RIVERNORTH FLEX MUNI II (RFMZ) Stock Price, Quote, News and Overview

NYSE:RFMZ - New York Stock Exchange, Inc. - US76883Y1073 - Currency: USD

12.523  -0.01 (-0.06%)

Fundamental Rating

2

Overall RFMZ gets a fundamental rating of 2 out of 10. We evaluated RFMZ against 0 industry peers in the Unkown industry. RFMZ may be in some trouble as it scores bad on both profitability and health. RFMZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RFMZ had positive earnings in the past year.
In the past year RFMZ had a positive cash flow from operations.
RFMZ Yearly Net Income VS EBIT VS OCF VS FCFRFMZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 3.67%
ROE 6.04%
ROIC 1.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RFMZ Yearly ROA, ROE, ROICRFMZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

In the last couple of years the Profit Margin of RFMZ has declined.
RFMZ's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of RFMZ has grown nicely.
Industry RankSector Rank
OM 32.89%
PM (TTM) 84.07%
GM 31.41%
OM growth 3Y-0.11%
OM growth 5YN/A
PM growth 3Y-39.57%
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5YN/A
RFMZ Yearly Profit, Operating, Gross MarginsRFMZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 200 -200 400 -400

More info and screens

1

2. Health

2.1 Basic Checks

RFMZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RFMZ Yearly Shares OutstandingRFMZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
RFMZ Yearly Total Debt VS Total AssetsRFMZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M

2.2 Solvency

RFMZ has an Altman-Z score of 0.67. This is a bad value and indicates that RFMZ is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of RFMZ is 11.14, which is on the high side as it means it would take RFMZ, 11.14 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.64 indicates that RFMZ is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 11.14
Altman-Z 0.67
ROIC/WACCN/A
WACCN/A
RFMZ Yearly LT Debt VS Equity VS FCFRFMZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

2.3 Liquidity

RFMZ has a Current Ratio of 0.04. This is a bad value and indicates that RFMZ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.04 indicates that RFMZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
RFMZ Yearly Current Assets VS Current LiabilitesRFMZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

RFMZ shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.00%.
RFMZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.52% yearly.
Looking at the last year, RFMZ shows a small growth in Revenue. The Revenue has grown by 6.68% in the last year.
Measured over the past years, RFMZ shows a very strong growth in Revenue. The Revenue has been growing by 77.37% on average per year.
EPS 1Y (TTM)-7%
EPS 3Y7.52%
EPS 5YN/A
EPS Q2Q%-62.9%
Revenue 1Y (TTM)6.68%
Revenue growth 3Y77.37%
Revenue growth 5YN/A
Sales Q2Q%19.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RFMZ Yearly Revenue VS EstimatesRFMZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.47 indicates a correct valuation of RFMZ.
RFMZ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.93.
Industry RankSector Rank
PE 13.47
Fwd PE N/A
RFMZ Price Earnings VS Forward Price EarningsRFMZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 14.22
EV/EBITDA N/A
RFMZ Per share dataRFMZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.55%, RFMZ is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.32, RFMZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.55%

5.2 History

RFMZ has been paying a dividend for over 5 years, so it has already some track record.
The dividend of RFMZ decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
RFMZ Yearly Dividends per shareRFMZ Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

110.13% of the earnings are spent on dividend by RFMZ. This is not a sustainable payout ratio.
DP110.13%
EPS Next 2YN/A
EPS Next 3YN/A
RFMZ Yearly Income VS Free CF VS DividendRFMZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 -200M -400M -600M
RFMZ Dividend Payout.RFMZ Dividend Payout, showing the Payout Ratio.RFMZ Dividend Payout.PayoutRetained Earnings

More info and screens

RIVERNORTH FLEX MUNI II

NYSE:RFMZ (7/28/2025, 7:46:36 PM)

12.523

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.82%
Inst Owner Change1.74%
Ins Owners0.01%
Ins Owner Change1.02%
Market Cap304.94M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 7.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP110.13%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-15 2025-09-15 (0.0858)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.47
Fwd PE N/A
P/S 11.29
P/FCF 14.22
P/OCF 14.22
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)0.93
EY7.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.88
FCFY7.03%
OCF(TTM)0.88
OCFY7.03%
SpS1.11
BVpS15.4
TBVpS15.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 6.04%
ROCE 1.45%
ROIC 1.14%
ROICexc 1.14%
ROICexgc 1.15%
OM 32.89%
PM (TTM) 84.07%
GM 31.41%
FCFM 79.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.11%
OM growth 5YN/A
PM growth 3Y-39.57%
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 11.14
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.91
Cash Conversion N/A
Profit Quality 94.49%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 0.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7%
EPS 3Y7.52%
EPS 5YN/A
EPS Q2Q%-62.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.68%
Revenue growth 3Y77.37%
Revenue growth 5YN/A
Sales Q2Q%19.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.88%
EBIT growth 3Y77.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4025%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4025%
OCF growth 3YN/A
OCF growth 5YN/A